Omoruyi Osula, Ph.D.
Omoruyi Osula, Ph.D. is a registered patent agent. His practice includes patent-related risk assessments (including freedom-to-operate (FTO), IP due diligence investigations, non-infringement, and validity). Dr. Osula’s practice also includes patent procurement in the chemical, pharmaceutical, and biotechnology arts. His technical areas of expertise include pharmaceutical formulations, medical devices, antibody-based anti-cancer drugs, mass spectrometry, proteomics, and chromatography-based protein separation.
Dr. Osula’s doctoral research focused on developing mass spectrometry and protein cleavage-based methods for the improved identification of post-translationally modified mitotic proteins.
1. Osula, O.; Stephen, S.; Cotter, R.J. Identification of protein SUMOylation sites by mass spectrometry using combined microwave-assisted aspartic acid cleavage and tryptic digestion. Journal of Mass Spectrometry. 2012, 47, 644-654.
2. Cubenas-Potts, C.; Srikumar, T.; Lee, C.; Osula, O.; Subramonian, D., Zhang, X.-D., Cotter, R.J., Raught, B. and Matunis, M.J. Identification of SUMO2/3 modified proteins associated with mitotic chromosomes. Proteomics. 2015, 15, 763-772.
U.S. Patent and Trademark Office (USPTO)
Ph.D. Pharmacology, Johns Hopkins, School of Medicine
B.Sc. Biology, Morehouse College, magna cum laude, Phi Beta Kappa